Antiviral drugs can be used for treatment and prophylaxis of seasonal influenza (see Table 1). Frequently updated information on influenza activity, influenza testing, and antiviral resistance is available from the CDC at www.cdc.gov/flu.

ANTIVIRAL DRUGS — The neuraminidase inhibitors oseltamivir (Tamiflu, and generics), which is taken orally, and zanamivir (Relenza), which is inhaled, are FDA-approved for prophylaxis and treatment of acute uncomplicated influenza. The IV neuraminidase inhibitor peramivir...  Continue reading

Tildrakizumab-asmn (Ilumya – Sun), an interleukin (IL)-23 antagonist, has been approved by the FDA for treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Tildrakizumab is the second selective IL-23 antagonist to be approved for this indication; guselkumab (Tremfya) was the first.1

STANDARD TREATMENT — Topical corticosteroids are generally recommended for initial treatment of mild to moderate plaque psoriasis. The topical retinoid tazarotene (Tazorac, and others) and topical vitamin D analogs such as calcipotriene (Dovonex, and others) can also be used, alone or in combination with topical corticosteroids. For patients with moderate to severe disease, systemic ... Continue reading